JP Morgan maintains Overweight on Allient, raises price target to $95
JP Morgan analyst Tomohiko Sano maintained an Overweight rating on Allient (NASDAQ: ALNT) and raised the price target to $95 from $80.

*this image is generated using AI for illustrative purposes only.
JP Morgan analyst Tomohiko Sano has maintained an Overweight rating on Allient (NASDAQ: ALNT) and raised the price target to $95 from $80. The adjustment reflects a revised outlook on the stock's valuation potential.
Rating and Price Target
The brokerage's decision to upgrade the price target comes as it retains its positive stance on the company. The new target of $95 represents an increase from the prior level of $80.
| Metric | Value |
|---|---|
| Rating | Overweight |
| Previous Price Target | $80 |
| New Price Target | $95 |
What specific factors drove the revision in Allient's valuation potential?
How might Allient's recent performance influence other analysts' ratings?
What are the key risks that could prevent Allient from reaching the new $95 price target?























